NHS trusts: area prevalence for sickle cell and thalassaemia
- Public Health England
- Part of:
- Sickle cell and thalassaemia screening: commission and provide
- First published:
- 1 January 2012
- Last updated:
- 20 August 2015, see all updates
These documents list sickle cell and thalassaemia high and low prevalence NHS Trusts in England and explain how prevalence is determined.
NHS sickle cell and thalassaemia screening programme: combined list of high prevalence and low prevalence trusts
PDF, 93.7KB, 2 pages
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email email@example.com. Please tell us what format you need. It will help us if you say what assistive technology you use.
PDF, 81.7KB, 2 pages
This publication divides the NHS trusts into 2 groups based on their levels of prevalence of sickle cell and thalassaemia:
- high prevalence
- low prevalence
For some trusts individual hospitals have their own level of prevalence.
Sickle Cell and Thalassaemia determining prevalence includes:
- definitions of high and low prevalence
- pathway guidance for high and low prevalence trusts
- recommended algorithms
Published: 1 January 2012
Updated: 20 August 2015
- Updated document for accuracy
- First published.